Grail (GRAL) EPS (Basic) (2023 - 2026)
Grail's (GRAL) quarterly EPS (Basic) came in at -$2.56 in Q2 2026, up 19.7% on a YoY basis from -$2.14 in Q2 2025, and down 11.52% quarter-over-quarter from -$2.29 in Q1 2026.
Powered by 
Analysis
Grail (GRAL) EPS (Basic) (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported EPS (Basic) for 4 consecutive years, with -$2.56 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 19.7% year-over-year to -$2.56; the trailing twelve-month figure through Jun 2026 stood at -$9.08 (up 26.6% YoY), and the FY2025 full-year result was -$11.11, up 82.51% from the prior year.
- EPS (Basic) declined to -$2.56 in Q2 2026 per GRAL's latest filing, from -$2.29 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$2.29 in Q1 2026 and bottomed at -$51.06 in Q2 2024.
- Historically, EPS (Basic) has averaged -$9.41 across 4 years, with a median of -$3.18 in 2025.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) plunged 721.23% in 2024, then soared 93.76% in 2025.
- Over 4 years, EPS (Basic) stood at -$6.04 in 2023, then soared by 49.62% to -$3.04 in 2024, then grew by 11.32% to -$2.7 in 2025, then advanced by 5.23% to -$2.56 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$2.56, -$2.29, and -$2.7 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -0.47 |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 2.92 |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 3.66 |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -0.90 |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 0.05 |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 0.00 |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 0.19 |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 0.17 |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -0.10 |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -2.56 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.56 |
| Mar 31, 2026 | -2.29 |
| Dec 31, 2025 | -2.70 |
| Sep 30, 2025 | -2.46 |
| Jun 30, 2025 | -3.18 |
| Mar 31, 2025 | -3.10 |
| Dec 31, 2024 | -3.04 |
| Sep 30, 2024 | -3.94 |
| Jun 30, 2024 | -51.06 |
| Mar 31, 2024 | -7.05 |
| Dec 31, 2023 | -6.04 |
| Oct 1, 2023 | -28.71 |
| Jun 30, 2023 | -6.22 |